These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34336636)

  • 1. Progesterone Receptor Expression in Meningiomas: Pathological and Prognostic Implications.
    Maiuri F; Mariniello G; de Divitiis O; Esposito F; Guadagno E; Teodonno G; Barbato M; Del Basso De Caro M
    Front Oncol; 2021; 11():611218. PubMed ID: 34336636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.
    Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M
    Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentric and diffuse recurrences of meningiomas.
    Maiuri F; Mariniello G; Peca C; Guadagno E; Corvino S; d'Avanzo S; Del Basso De Caro M; de Divitiis O
    Br J Neurosurg; 2020 Aug; 34(4):439-446. PubMed ID: 32312105
    [No Abstract]   [Full Text] [Related]  

  • 4. Single versus multiple reoperations for recurrent intracranial meningiomas.
    Maiuri F; Corvino S; Corazzelli G; Del Basso De Caro M
    J Neurooncol; 2024 Jul; 168(3):527-535. PubMed ID: 38656725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
    Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
    Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local versus diffuse recurrences of meningiomas: factors correlated to the extent of the recurrence.
    Maiuri F; Donzelli R; Mariniello G; Del Basso De Caro ML; Colella A; Peca C; Vergara P; Pettinato G
    Clin Neuropathol; 2008; 27(1):29-36. PubMed ID: 18257472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence.
    Csonka T; Murnyák B; Szepesi R; Bencze J; Bognár L; Klekner A; Hortobágyi T
    Folia Neuropathol; 2016; 54(2):114-26. PubMed ID: 27543769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of spinal meningiomas: analysis of the risk factors.
    Maiuri F; Del Basso De Caro M; de Divitiis O; Guadagno E; Mariniello G
    Br J Neurosurg; 2020 Oct; 34(5):569-574. PubMed ID: 31290345
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors in anterior skull base meningiomas.
    Ciocan LM; Dănăilă L; Stănculescu DE; Neamţu SD; Mateescu GO; Stanca L
    Rom J Morphol Embryol; 2014; 55(3 Suppl):1063-9. PubMed ID: 25607386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
    Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
    J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningiomas in Premenopausal Women: Role of the Hormone Related Conditions.
    Maiuri F; Mariniello G; Somma T; Guadagno E; Corvino S; Pagano S; Orlando V; Del Basso De Caro M
    Front Oncol; 2020; 10():556701. PubMed ID: 33363003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone Receptor Is Responsible for Benign Biology of Skull Base Meningioma.
    Kuroi Y; Matsumoto K; Shibuya M; Kasuya H
    World Neurosurg; 2018 Oct; 118():e918-e924. PubMed ID: 30031954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
    Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
    J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningioma Prognostic Tool Based on Correlation of Histopathological Grading and Immunohistochemistry.
    Shafat M; Khursheed N; Walvir N; Makhdoomi R; Ayesha Z
    Oman Med J; 2024 Mar; 39(2):e608. PubMed ID: 39055905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.
    Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E
    J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
    Hsu DW; Efird JT; Hedley-Whyte ET
    J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of meningioma with special reference to prognostic utility of ER,PR and Ki67 expression.
    Mukhopadhyay M; Das C; Kumari M; Sen A; Mukhopadhyay B; Mukhopadhyay B
    J Lab Physicians; 2017; 9(4):308-313. PubMed ID: 28966496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
    Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
    Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone receptor expression and Ki-67 labelling index of meningiomas in the Lagos university teaching hospital.
    Ikeri NZ; Anunobi CC; Bankole OB
    Niger Postgrad Med J; 2018; 25(1):17-20. PubMed ID: 29676340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas].
    Hernández Faraco A; Céspedes G; Trejo E
    Neurologia; 2009 May; 24(4):235-44. PubMed ID: 19603293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.